이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!
Dermapharm Holding 대차 대조표 상태
재무 상태 기준 확인 3/6
Dermapharm Holding 의 총 주주 지분은 €587.2M 이고 총 부채는 €1.0B, 이는 부채 대 자기자본 비율을 175.3% 로 가져옵니다. 총자산과 총부채는 각각 €2.2B 및 €1.6B 입니다. Dermapharm Holding 의 EBIT는 €176.5M 이며 이자보상배율은 4.3 입니다. €117.4M 의 현금 및 단기 투자금을 보유하고 있습니다.
주요 정보
190.5%
부채 비율
€1.06b
부채
| 이자 보상 비율 | 3.7x |
| 현금 | €165.76m |
| 주식 | €556.43m |
| 총 부채 | €1.65b |
| 총 자산 | €2.21b |
최근 재무 상태 업데이트
Here's Why Dermapharm Holding (ETR:DMP) Has A Meaningful Debt Burden
Sep 28
These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Recent updates
Here's Why Dermapharm Holding (ETR:DMP) Has A Meaningful Debt Burden
Sep 28Dermapharm Holding SE Beat Revenue Forecasts By 6.7%: Here's What Analysts Are Forecasting Next
Aug 31Dermapharm Holding SE's (ETR:DMP) P/E Still Appears To Be Reasonable
Aug 17It Looks Like Dermapharm Holding SE's (ETR:DMP) CEO May Expect Their Salary To Be Put Under The Microscope
Jun 21These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Extensively
Apr 29Dermapharm Holding SE's (ETR:DMP) Price In Tune With Earnings
Feb 07Dermapharm Holding (ETR:DMP) Seems To Use Debt Quite Sensibly
Dec 15An Intrinsic Calculation For Dermapharm Holding SE (ETR:DMP) Suggests It's 24% Undervalued
Nov 17Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
Aug 28Dermapharm Holding SE's (ETR:DMP) Intrinsic Value Is Potentially 76% Above Its Share Price
Aug 01Dermapharm Holding (ETR:DMP) Has A Pretty Healthy Balance Sheet
May 29Is Dermapharm Holding SE (ETR:DMP) Trading At A 44% Discount?
May 03Dermapharm Holding's (ETR:DMP) Soft Earnings Are Actually Better Than They Appear
Apr 04We Think Dermapharm Holding (ETR:DMP) Can Stay On Top Of Its Debt
Feb 22Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Nov 17Is Dermapharm Holding (ETR:DMP) A Risky Investment?
Aug 16Is Dermapharm Holding (ETR:DMP) A Risky Investment?
May 18Is Dermapharm Holding (ETR:DMP) Using Too Much Debt?
Feb 17These 4 Measures Indicate That Dermapharm Holding (ETR:DMP) Is Using Debt Reasonably Well
Nov 19Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Aug 21Is Dermapharm Holding SE (ETR:DMP) Trading At A 28% Discount?
Jul 31Is Dermapharm Holding SE (ETR:DMP) The Right Choice For A Smart Dividend Investor?
May 03Calculating The Intrinsic Value Of Dermapharm Holding SE (ETR:DMP)
Apr 16Here's Why Dermapharm Holding (ETR:DMP) Can Manage Its Debt Responsibly
Mar 25Did You Miss Dermapharm Holding's (ETR:DMP) Impressive 110% Share Price Gain?
Mar 07Is Dermapharm Holding SE's (ETR:DMP) 27% ROE Better Than Average?
Feb 15Something To Consider Before Buying Dermapharm Holding SE (ETR:DMP) For The 1.4% Dividend
Jan 29Does Dermapharm Holding (ETR:DMP) Have A Healthy Balance Sheet?
Dec 24
The Dermapharm Holding (ETR:DMP) Share Price Has Gained 45% And Shareholders Are Hoping For More
Dec 07Dermapharm Holding SE Just Missed Earnings - But Analysts Have Updated Their Models
Nov 18재무 상태 분석
단기부채: DMP 의 단기 자산 ( €648.9M )이 단기 부채( €414.3M ).
장기 부채: DMP 의 단기 자산( €648.9M )은 장기 부채( €1.2B ).
부채 대 자본 내역 및 분석
부채 수준: DMP 의 순부채 대 자기자본 비율( 155.3% )은 높음으로 간주됩니다.
부채 감소: DMP 의 부채 대 자기자본 비율은 지난 5년간 179.4% 에서 175.3% 로 감소했습니다.
부채 범위: DMP 의 부채는 영업 현금 흐름 ( 17.4% )에 의해 잘 갚지 않음입니다.
이자 보장: DMP 의 부채에 대한 이자 지급은 EBIT( 4.3 x 적용 범위)로 잘 충당됩니다.